Skip to main content

Table 1 Patient and tumor characteristics

From: Indocyanine green fluorescence imaging during laparoscopic rectal cancer surgery could reduce the incidence of anastomotic leakage: a single institutional retrospective cohort study

 

ICG group (n = 73)

Non-ICG group (n = 114)

p-value

Sex, n (%)

  

0.524

  Male

46 (63%)

77 (67.5%)

 

  Female

27 (37%)

37 (32.5%)

 

Age, yearsa

67 (57, 72)

68 (59, 73)

0.517

BMIa

22.7 (20.7, 25.1)

22.2 (19.9, 24.8)

0.371

Comorbidities, n (%)

  Hypertension

22 (30.1%)

36 (31.6%)

0.835

  Diabetes

18 (24.6%)

17 (14.9%)

0.096

  Cardiac dysfunction

9 (12.3%)

15 (13.2%)

0.868

  Pulmonary dysfunction

9 (12.3%)

10 (8.8%)

0.432

Preoperative therapy, n (%)

  

0.010

  Chemoradiotherapy

8 (10.9%)

3 (2.6%)

 

  Chemotherapy

5 (6.9%)

2 (1.8%)

 

Tumor size, mma

30 (20, 50)

35 (20, 50)

0.160

Tumor location, n (%)

  

0.478

  Upper rectum

35 (47.9%)

47 (41.2%)

 

  Middle rectum

8 (11%)

19 (16.7%)

 

  Low rectum

30 (41.1%)

48 (42.1%)

 

Tumor staging, n (%)

  Stage I

21 (28.7%)

33 (28.9%)

 

  Stage II

18 (24.6%)

27 (23.7%)

 

  Stage III

25 (34.2%)

40 (35.1%)

 

  Stage IV

9 (12.5%)

14 (12.3%)

 
  1. ICG indocyanine green, BMI body mass index
  2. aValues are shown as median (interquartile range)